Impact of intravesical administration of tranexamic acid on gross hematuria in the emergency department: A before-and-after study

Am J Emerg Med. 2023 Jun:68:68-72. doi: 10.1016/j.ajem.2023.03.020. Epub 2023 Mar 16.

Abstract

Introduction: Local applications of tranexamic acid (TXA) have been effective in treating various hemorrhagic conditions. In patients with gross hematuria, the main treatment in the emergency department (ED) is continuous bladder irrigation (CBI). However, CBI has no pharmacological effects except blood clot removal from dilution. The aim of this study was to evaluate the impact of the intravesical TXA injection before CBI.

Methods: This study was a before-and-after, retrospective, and single-center study. The target population was hematuria patients who received CBI via a 3-way Foley catheter. As the intervention procedure, 1000 mg of TXA was injected through the Foley catheter and after 15 min, the Foley catheter was declamped and CBI started. Since the intervention started in March 2022, the patients from March 2022 to August 2022 were assigned to the after group and the patients from March 2021 to August 2021 were assigned to the before group. The primary outcomes were the length of stay in the ED and duration of Foley catheter placement. The secondary outcomes were the admissions and the revisits for CBI within 48 h after discharge.

Results: The numbers of patients in the before group and after group were 73 and 86, respectively. The median length of stay in the ED was shorter in the intervention group than in the group not treated with TXA (274 min vs. 411 mins, P < 0.001). The median duration of Foley catheter placement was also shorter in the intervention group than not treated with TXA (145 min vs. 308 mins, P < 0.001). The revisits after ED discharge were lower in the after group than in the before group (2.3% vs. 12.3%, P = 0.031). There was a trend for lower admissions in the TXA treatment group than before group (29.1% vs. 45.2%, P = 0.052).

Conclusion: After the TXA intervention, reduction in the length of stay in the ED, the duration of Foley catheter placement, and the revisits after ED discharge was observed.

Keywords: Hematuria; Length of stay; Tranexamic acid.

MeSH terms

  • Administration, Intravesical
  • Antifibrinolytic Agents* / therapeutic use
  • Emergency Service, Hospital
  • Hematuria / drug therapy
  • Humans
  • Retrospective Studies
  • Tranexamic Acid* / therapeutic use
  • Treatment Outcome

Substances

  • Tranexamic Acid
  • Antifibrinolytic Agents